Gufic Biosciences Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue growth in latest quarter indicates resilience despite market pressures.
Profit margins have shown a marginal improvement, reflecting better cost management.
Operating profit margin has stabilized, suggesting operational efficiency is being maintained.

NEGATIVES

Net profit has declined significantly in latest quarter compared to earlier periods.
Expenses have increased, impacting overall profitability despite revenue growth.
Interest expenses have risen, indicating higher financial costs affecting net earnings.

Field	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Jun 25
Revenue	214.87	201.78	194.99	202.81	204.18	207.79	223.72
Expenses	184.26	172.64	168.76	175.96	175.04	183.40	207.37
Operating Profit	30.61	29.13	26.24	26.85	29.14	24.40	16.35
Other Income	0.33	0.42	0.88	1.26	0.11	1.86	0.93
Interest	4.46	3.18	3.65	4.62	5.18	4.91	9.23
Depreciation	4.30	4.14	4.34	4.30	4.30	4.62	7.72
Profit Before Tax	30.95	29.56	27.12	28.11	29.25	26.26	17.27
Tax	7.74	7.30	7.07	7.25	7.48	6.96	4.20
Net Profit	23.21	22.26	20.05	20.86	21.77	19.30	13.07
Eps in Rs	2.39	2.23	2	2.08	2.17	1.93	1.30